Australia, Jan. 7 -- Neuren Pharmaceuticals Ltd. (NEU) has reported gross short sales of 60,998 FPO NZ shares on Jan. 3. The percent of issued capital of the company reported as short sales is 0.04 percent. The issued capital of the company is 127,815,676 shares.
Disclaimer: Curated by HT Syndication.
